067080

18,990 KRW
160
0.85%
Last update Dec 17, 3:00 PM KST
Post-market
Day range
18,550
19,120
Previous close
18,830
Open
18,900
Access this stock data via API
Subscribe
Daehwa Pharm Co. Ltd.
18,990.00
160
0.85%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 36.7B 36.0B 36.7B 40.1B
Cost of revenue 24.5B 24.2B 24.7B 24.1B
Gross profit 12.2B 11.8B 11.9B 16.0B
Operating expense
Research & development 1.1B 1.5B 1.2B 1.7B
Selling general and admin 6.3B 6.5B 6.1B 7.6B
Other operating expenses 522.6M 158.0M 58.7M -102.3M
Operating income 1.0B 285.2M 1.1B 3.4B
Non operating interest income
Income -16.6M 865K 26.1M -42.8M
Expense 1.1B 1.2B 1.3B 1.4B
Other income expense
Pretax income 286.3M -362.4M -144.1M 1.7B
Tax provision 465.1M 154.8M 153.1M 312.0M
Net income -178.8M -517.2M -297.2M 1.4B
Basic EPS -24 -39 -24
Diluted EPS -24 -39 -24
Basic average shares 17.9M 17.5M 17.5M
Diluted average shares 17.9M 17.5M 17.5M
EBITDA 2.8B 2.4B 2.8B 5.0B
Net income from continuing op. -178.8M -517.2M -297.2M 1.4B
Minority interests -249.8M -165.0M -117.0M 189.3M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Post-market

Exchange is currently open for post-market.
Post market session closes in 1 hour 54 minutes

16:06
00:00
09:00
15:30
23:59

Trading Hours (Monday - Friday):

Pre-market
07:30 - 09:00
Main market
09:00 - 15:30
Post-market
15:30 - 18:00
All times are displayed in the Asia/Seoul timezone (KST, UTC+09:00).